EUVIMEDEUVIMED entdecken
Crossref

Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model

Hedwig M Blommestein, Saskia de Groot, Brenda Leeneman, Carin A Uyl-de Groot, John B A G Haanen, Michel W J M Wouters, Maureen J B Aarts, Franchette W P J van den Berkmortel, Willeke A M Blokx, Marye J Boers-Sonderen, Alfons J M van den Eertwegh, Jan Willem B de Groot und 6 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2024.115071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Hedwig M Blommestein und 17 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus School of Health Policy and Management, Erasmus University Rotterdam, the Netherlands. Electronic address: blommestein@ehspm.eur.nl. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Melanoma, Mutation, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafMelanomaMutationSkin NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansCost-Benefit AnalysisNetherlandsModels, EconomicQuality-Adjusted Life YearsMarkov ChainsDrug CostsMaleFemale

Stichwörter der Autor:innen

BinimetinibCost-Effectiveness AnalysisDrug CostsEncorafenibImmunotherapyIpilimumabMelanomaNivolumabProto-Oncogene Proteins B-rafQuality-Adjusted Life Years

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Erasmus School of Health Policy and Management, Erasmus University Rotterdam, the Netherlands. Electronic address: blommestein@ehspm.eur.nl.
  • Erasmus School of Health Policy and Management, Erasmus University Rotterdam, the Netherlands; Institute for Medical Technology Assessment, Erasmus University Rotterdam, the Netherlands.
  • Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Department of Biomedi…
  • Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Department of Medical Oncology, Zuyderland Medical Center Sittard, Sittard-Geleen, the Netherlands.

Zitieren

APA

Blommestein, H. M., de Groot, S., Leeneman, B., Uyl-de Groot, C. A., Haanen, J. B. A. G., Wouters, M. W. J. M., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blokx, W. A. M., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., van Not, O. J., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., & Franken, M. G. (2025). Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115071

Vancouver

Blommestein HM, de Groot S, Leeneman B, Uyl-de Groot CA, Haanen JBAG, Wouters MWJM, et al. Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2024.115071

BibTeX
@article{Blommestein2025,
  author = {Blommestein, Hedwig M and de Groot, Saskia and Leeneman, Brenda and Uyl-de Groot, Carin A and Haanen, John B A G and Wouters, Michel W J M and Aarts, Maureen J B and van den Berkmortel, Franchette W P J and Blokx, Willeke A M and Boers-Sonderen, Marye J and van den Eertwegh, Alfons J M and de Groot, Jan Willem B and Hospers, Geke A P and Kapiteijn, Ellen and van Not, Olivier J and van der Veldt, Astrid A M and Suijkerbuijk, Karijn P M and Franken, Margreet G},
  title = {Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2024.115071}
}
Kostenlos starten →